DD284236A5 - Verfahren zur herstellung neuer thieno(3',4'-4,5)imidazo(2,1-b)thiazol-derivate - Google Patents

Verfahren zur herstellung neuer thieno(3',4'-4,5)imidazo(2,1-b)thiazol-derivate Download PDF

Info

Publication number: DD284236A5
Authority: DD; German Democratic Republic
Prior art keywords: formula; hydrogen; minutes; imidazo; alkyl
Prior art date: 1988-09-08

Application number

DD89332414A

Other languages

German (de)

English (en)

Inventor

Dieter Binder

Franz Rovenszky

Peter H Ferber

Original Assignee

��@��@��@��k��

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1988-09-08

Filing date

1989-09-06

Publication date

1990-11-07

1989-09-06 Application filed by ��@��@��@��k�� filed Critical ��@��@��@��k��

1990-11-07 Publication of DD284236A5 publication Critical patent/DD284236A5/de

Links

GKTQKQTXHNUFSP-UHFFFAOYSA-N thieno[3,4-c]pyrrole-4,6-dione Chemical compound S1C=C2C(=O)NC(=O)C2=C1 GKTQKQTXHNUFSP-UHFFFAOYSA-N 0.000 title claims description 11
UFBBWLWUIISIPW-UHFFFAOYSA-N imidazo[2,1-b][1,3]thiazole Chemical class C1=CSC2=NC=CN21 UFBBWLWUIISIPW-UHFFFAOYSA-N 0.000 title claims description 4
238000004519 manufacturing process Methods 0.000 title abstract 2
150000003839 salts Chemical class 0.000 claims abstract description 17
238000000034 method Methods 0.000 claims abstract description 16
238000002360 preparation method Methods 0.000 claims abstract description 8
239000003153 chemical reaction reagent Substances 0.000 claims abstract description 6
238000007127 saponification reaction Methods 0.000 claims abstract 3
150000001875 compounds Chemical class 0.000 claims description 28
XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 claims description 14
229910052739 hydrogen Inorganic materials 0.000 claims description 12
239000001257 hydrogen Substances 0.000 claims description 12
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 9
150000002431 hydrogen Chemical group 0.000 claims description 8
239000002904 solvent Substances 0.000 claims description 7
238000010992 reflux Methods 0.000 claims description 6
125000000217 alkyl group Chemical group 0.000 claims description 5
238000007363 ring formation reaction Methods 0.000 claims description 5
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 4
239000002253 acid Substances 0.000 claims description 4
238000009835 boiling Methods 0.000 claims description 3
229910052736 halogen Inorganic materials 0.000 claims description 3
150000002367 halogens Chemical group 0.000 claims description 3
150000007529 inorganic bases Chemical class 0.000 claims description 3
150000007530 organic bases Chemical class 0.000 claims description 3
229920000137 polyphosphoric acid Polymers 0.000 claims description 2
210000000987 immune system Anatomy 0.000 abstract description 6
206010028980 Neoplasm Diseases 0.000 abstract description 3
201000011510 cancer Diseases 0.000 abstract description 3
150000002148 esters Chemical class 0.000 abstract description 3
206010039073 rheumatoid arthritis Diseases 0.000 abstract description 3
238000011282 treatment Methods 0.000 abstract description 3
230000002950 deficient Effects 0.000 abstract description 2
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 27
239000000126 substance Substances 0.000 description 12
239000000243 solution Substances 0.000 description 10
238000012360 testing method Methods 0.000 description 8
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
239000002671 adjuvant Substances 0.000 description 6
UVNXNSUKKOLFBM-UHFFFAOYSA-N imidazo[2,1-b][1,3,4]thiadiazole Chemical compound N1=CSC2=NC=CN21 UVNXNSUKKOLFBM-UHFFFAOYSA-N 0.000 description 6
125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 description 6
PUYFLGQZLHVTHX-UHFFFAOYSA-N tilomisole Chemical compound OC(=O)CC=1SC2=NC3=CC=CC=C3N2C=1C1=CC=C(Cl)C=C1 PUYFLGQZLHVTHX-UHFFFAOYSA-N 0.000 description 6
YXTMFYBABGJSBY-UHFFFAOYSA-N 2-(1,3-thiazol-2-yl)acetic acid Chemical compound OC(=O)CC1=NC=CS1 YXTMFYBABGJSBY-UHFFFAOYSA-N 0.000 description 5
-1 for example Substances 0.000 description 5
230000000144 pharmacologic effect Effects 0.000 description 5
229920002134 Carboxymethyl cellulose Polymers 0.000 description 4
CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 4
235000010948 carboxy methyl cellulose Nutrition 0.000 description 4
239000003814 drug Substances 0.000 description 4
229940126062 Compound A Drugs 0.000 description 3
YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
NLDMNSXOCDLTTB-UHFFFAOYSA-N Heterophylliin A Natural products O1C2COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(O)C1OC(=O)C1=CC(O)=C(O)C(O)=C1 NLDMNSXOCDLTTB-UHFFFAOYSA-N 0.000 description 3
206010036030 Polyarthritis Diseases 0.000 description 3
241000700159 Rattus Species 0.000 description 3
ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
229960000583 acetic acid Drugs 0.000 description 3
230000003110 anti-inflammatory effect Effects 0.000 description 3
206010003246 arthritis Diseases 0.000 description 3
239000002585 base Substances 0.000 description 3
230000037396 body weight Effects 0.000 description 3
239000003795 chemical substances by application Substances 0.000 description 3
239000013078 crystal Substances 0.000 description 3
229940079593 drug Drugs 0.000 description 3
239000012362 glacial acetic acid Substances 0.000 description 3
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
239000000825 pharmaceutical preparation Substances 0.000 description 3
208000030428 polyarticular arthritis Diseases 0.000 description 3
238000011321 prophylaxis Methods 0.000 description 3
239000011541 reaction mixture Substances 0.000 description 3
230000008961 swelling Effects 0.000 description 3
150000007979 thiazole derivatives Chemical class 0.000 description 3
238000005160 1H NMR spectroscopy Methods 0.000 description 2
QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 2
WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 2
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 2
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
241001465754 Metazoa Species 0.000 description 2
BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 2
PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
239000013543 active substance Substances 0.000 description 2
230000015572 biosynthetic process Effects 0.000 description 2
GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 2
229910052794 bromium Inorganic materials 0.000 description 2
125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
239000001768 carboxy methyl cellulose Substances 0.000 description 2
239000008112 carboxymethyl-cellulose Substances 0.000 description 2
238000006243 chemical reaction Methods 0.000 description 2
239000000460 chlorine Substances 0.000 description 2
229910052801 chlorine Inorganic materials 0.000 description 2
239000003085 diluting agent Substances 0.000 description 2
201000010099 disease Diseases 0.000 description 2
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
238000000605 extraction Methods 0.000 description 2
230000002519 immonomodulatory effect Effects 0.000 description 2
230000028993 immune response Effects 0.000 description 2
HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
WGUMZKCZDLPGHY-UHFFFAOYSA-N methyl 3-bromo-4-(4-chlorophenyl)-4-oxobutanoate Chemical compound COC(=O)CC(Br)C(=O)C1=CC=C(Cl)C=C1 WGUMZKCZDLPGHY-UHFFFAOYSA-N 0.000 description 2
239000000203 mixture Substances 0.000 description 2
239000012074 organic phase Substances 0.000 description 2
238000011160 research Methods 0.000 description 2
238000010517 secondary reaction Methods 0.000 description 2
229910052938 sodium sulfate Inorganic materials 0.000 description 2
235000011152 sodium sulphate Nutrition 0.000 description 2
239000007858 starting material Substances 0.000 description 2
230000004936 stimulating effect Effects 0.000 description 2
230000000638 stimulation Effects 0.000 description 2
238000003756 stirring Methods 0.000 description 2
229950002145 tilomisole Drugs 0.000 description 2
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 1
GFTPLFVZKMIYAP-UHFFFAOYSA-N 2-(1h-benzimidazol-1-ium-2-yl)acetate Chemical compound C1=CC=C2NC(CC(=O)O)=NC2=C1 GFTPLFVZKMIYAP-UHFFFAOYSA-N 0.000 description 1
FOBRDHSBOUMWDA-UHFFFAOYSA-N 2-imidazo[2,1-b][1,3]thiazol-2-ylacetic acid Chemical compound C1=CN=C2SC(CC(=O)O)=CN21 FOBRDHSBOUMWDA-UHFFFAOYSA-N 0.000 description 1
BKPIBJGEDQUKPJ-UHFFFAOYSA-N 3-(4-chlorophenyl)-2h-1,3-thiazole Chemical compound C1=CC(Cl)=CC=C1N1C=CSC1 BKPIBJGEDQUKPJ-UHFFFAOYSA-N 0.000 description 1
PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
108010010803 Gelatin Proteins 0.000 description 1
229920000084 Gum arabic Polymers 0.000 description 1
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
206010021450 Immunodeficiency congenital Diseases 0.000 description 1
GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
241000186359 Mycobacterium Species 0.000 description 1
ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
241000978776 Senegalia senegal Species 0.000 description 1
229920002472 Starch Polymers 0.000 description 1
GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
239000000205 acacia gum Substances 0.000 description 1
235000010489 acacia gum Nutrition 0.000 description 1
229910001854 alkali hydroxide Inorganic materials 0.000 description 1
229910052783 alkali metal Inorganic materials 0.000 description 1
150000008044 alkali metal hydroxides Chemical class 0.000 description 1
150000001340 alkali metals Chemical class 0.000 description 1
229910052784 alkaline earth metal Inorganic materials 0.000 description 1
125000005210 alkyl ammonium group Chemical group 0.000 description 1
125000005263 alkylenediamine group Chemical group 0.000 description 1
150000001412 amines Chemical class 0.000 description 1
229910021529 ammonia Inorganic materials 0.000 description 1
150000003863 ammonium salts Chemical class 0.000 description 1
238000010171 animal model Methods 0.000 description 1
NDKBVBUGCNGSJJ-UHFFFAOYSA-M benzyltrimethylammonium hydroxide Chemical compound [OH-].C[N+](C)(C)CC1=CC=CC=C1 NDKBVBUGCNGSJJ-UHFFFAOYSA-M 0.000 description 1
244000309464 bull Species 0.000 description 1
159000000007 calcium salts Chemical class 0.000 description 1
239000002775 capsule Substances 0.000 description 1
125000004432 carbon atom Chemical group C* 0.000 description 1
239000000969 carrier Substances 0.000 description 1
238000004440 column chromatography Methods 0.000 description 1
125000000753 cycloalkyl group Chemical group 0.000 description 1
HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 1
239000012153 distilled water Substances 0.000 description 1
239000008298 dragée Substances 0.000 description 1
239000000839 emulsion Substances 0.000 description 1
238000002474 experimental method Methods 0.000 description 1
229910052731 fluorine Inorganic materials 0.000 description 1
239000011737 fluorine Substances 0.000 description 1
238000009472 formulation Methods 0.000 description 1
239000008273 gelatin Substances 0.000 description 1
229920000159 gelatin Polymers 0.000 description 1
235000019322 gelatine Nutrition 0.000 description 1
235000011852 gelatine desserts Nutrition 0.000 description 1
230000002068 genetic effect Effects 0.000 description 1
238000010438 heat treatment Methods 0.000 description 1
229910000042 hydrogen bromide Inorganic materials 0.000 description 1
125000002768 hydroxyalkyl group Chemical group 0.000 description 1
NBGMRMDAEWWFIR-UHFFFAOYSA-N imidazole-2-thione Chemical compound S=C1N=CC=N1 NBGMRMDAEWWFIR-UHFFFAOYSA-N 0.000 description 1
230000008105 immune reaction Effects 0.000 description 1
239000002955 immunomodulating agent Substances 0.000 description 1
229940121354 immunomodulator Drugs 0.000 description 1
238000010874 in vitro model Methods 0.000 description 1
238000011835 investigation Methods 0.000 description 1
229910052740 iodine Inorganic materials 0.000 description 1
125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
238000002955 isolation Methods 0.000 description 1
125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
239000008101 lactose Substances 0.000 description 1
238000011694 lewis rat Methods 0.000 description 1
239000007788 liquid Substances 0.000 description 1
239000011777 magnesium Substances 0.000 description 1
229910052749 magnesium Inorganic materials 0.000 description 1
235000019359 magnesium stearate Nutrition 0.000 description 1
229910052751 metal Inorganic materials 0.000 description 1
239000002184 metal Substances 0.000 description 1
SLONBSAYACJVRR-UHFFFAOYSA-N methyl 4-(4-chlorophenyl)-4-oxobutanoate Chemical compound COC(=O)CCC(=O)C1=CC=C(Cl)C=C1 SLONBSAYACJVRR-UHFFFAOYSA-N 0.000 description 1
238000002156 mixing Methods 0.000 description 1
238000006386 neutralization reaction Methods 0.000 description 1
BATYZROLQBKDMN-UHFFFAOYSA-N o-methyl 4-(4-chlorophenyl)-4-oxo-3-(1h-thieno[3,4-d]imidazol-2-yl)butanethioate Chemical compound N=1C2=CSC=C2NC=1C(CC(=S)OC)C(=O)C1=CC=C(Cl)C=C1 BATYZROLQBKDMN-UHFFFAOYSA-N 0.000 description 1
239000003921 oil Substances 0.000 description 1
235000019198 oils Nutrition 0.000 description 1
239000002674 ointment Substances 0.000 description 1
230000003204 osmotic effect Effects 0.000 description 1
230000001575 pathological effect Effects 0.000 description 1
239000000546 pharmaceutical excipient Substances 0.000 description 1
229920001515 polyalkylene glycol Polymers 0.000 description 1
239000011591 potassium Substances 0.000 description 1
229910052700 potassium Inorganic materials 0.000 description 1
239000003755 preservative agent Substances 0.000 description 1
125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
238000000746 purification Methods 0.000 description 1
230000035484 reaction time Effects 0.000 description 1
238000001953 recrystallisation Methods 0.000 description 1
229930195734 saturated hydrocarbon Natural products 0.000 description 1
239000011734 sodium Substances 0.000 description 1
229910052708 sodium Inorganic materials 0.000 description 1
239000007787 solid Substances 0.000 description 1
239000003381 stabilizer Substances 0.000 description 1
239000008107 starch Substances 0.000 description 1
235000019698 starch Nutrition 0.000 description 1
239000000829 suppository Substances 0.000 description 1
239000000725 suspension Substances 0.000 description 1
239000003826 tablet Substances 0.000 description 1
239000000454 talc Substances 0.000 description 1
229910052623 talc Inorganic materials 0.000 description 1
235000012222 talc Nutrition 0.000 description 1
125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 1
LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
229940099259 vaseline Drugs 0.000 description 1
235000015112 vegetable and seed oil Nutrition 0.000 description 1
239000008158 vegetable oil Substances 0.000 description 1
238000010626 work up procedure Methods 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains three hetero rings
- C07D513/14—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Engineering & Computer Science (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

DD89332414A 1988-09-08 1989-09-06 Verfahren zur herstellung neuer thieno(3',4'-4,5)imidazo(2,1-b)thiazol-derivate DD284236A5 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
AT0220288A AT394046B (de)	1988-09-08	1988-09-08	Neue thieno(3',4'-4,5)imidazo(2,1-b)thiazolderivate, verfahren zu ihrer herstellung und ihre verwendung

Publications (1)

Publication Number	Publication Date
DD284236A5 true DD284236A5 (de)	1990-11-07

Family

ID=3529895

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DD89332414A DD284236A5 (de)	1988-09-08	1989-09-06	Verfahren zur herstellung neuer thieno(3',4'-4,5)imidazo(2,1-b)thiazol-derivate

Country Status (23)

Country	Link
US (1)	US4978671A (lt)
EP (1)	EP0358116A3 (lt)
JP (1)	JPH02115189A (lt)
KR (1)	KR900004747A (lt)
CN (1)	CN1025197C (lt)
AT (1)	AT394046B (lt)
AU (1)	AU616301B2 (lt)
CS (1)	CS275035B2 (lt)
DD (1)	DD284236A5 (lt)
DK (1)	DK441689A (lt)
FI (1)	FI89363C (lt)
HU (1)	HU201330B (lt)
IL (1)	IL91544A0 (lt)
LT (1)	LT3946B (lt)
MY (1)	MY105044A (lt)
NO (1)	NO893428L (lt)
NZ (1)	NZ230555A (lt)
PH (1)	PH26102A (lt)
PT (1)	PT91656B (lt)
SU (1)	SU1739851A3 (lt)
UA (1)	UA13480A (lt)
YU (1)	YU171789A (lt)
ZA (1)	ZA896682B (lt)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4214089A (en) *	1978-07-18	1980-07-22	American Home Products Corporation	Thiazolo[3,2-a]benzimidazoles, imidazo [2,1-b]thiazoles, and related compounds as antineoplastic agents, and enhancers of the immune response
CA1131226A (en) *	1978-09-28	1982-09-07	Tomohiko Munakata	Heterocyclic compounds
US4293696A (en) *	1980-12-22	1981-10-06	American Home Products Corporation	3-Substituted phenylthiazolo[3'2':1,2]imidazo[4,5-b]pyridine-2-alkanoic acids
EP0284893A3 (de) *	1987-04-03	1990-04-18	Hafslund Nycomed Pharma Aktiengesellschaft	Neue Thieno-imidazo(2,1-b)thiazol-Derivate, ein Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate

1988
- 1988-09-08 AT AT0220288A patent/AT394046B/de not_active IP Right Cessation
1989
- 1989-08-25 NO NO89893428A patent/NO893428L/no unknown
- 1989-08-26 MY MYPI89001176A patent/MY105044A/en unknown
- 1989-08-30 US US07/401,135 patent/US4978671A/en not_active Expired - Fee Related
- 1989-08-31 EP EP19890116131 patent/EP0358116A3/de not_active Withdrawn
- 1989-08-31 ZA ZA896682A patent/ZA896682B/xx unknown
- 1989-09-04 CS CS895106A patent/CS275035B2/cs unknown
- 1989-09-04 NZ NZ230555A patent/NZ230555A/xx unknown
- 1989-09-05 AU AU41098/89A patent/AU616301B2/en not_active Ceased
- 1989-09-06 IL IL91544A patent/IL91544A0/xx not_active IP Right Cessation
- 1989-09-06 FI FI894193A patent/FI89363C/fi not_active IP Right Cessation
- 1989-09-06 DD DD89332414A patent/DD284236A5/de not_active IP Right Cessation
- 1989-09-06 KR KR1019890012853A patent/KR900004747A/ko not_active Withdrawn
- 1989-09-06 PH PH39210A patent/PH26102A/en unknown
- 1989-09-07 DK DK441689A patent/DK441689A/da not_active Application Discontinuation
- 1989-09-07 JP JP1230584A patent/JPH02115189A/ja active Pending
- 1989-09-07 YU YU01717/89A patent/YU171789A/xx unknown
- 1989-09-07 HU HU894730A patent/HU201330B/hu not_active IP Right Cessation
- 1989-09-07 PT PT91656A patent/PT91656B/pt not_active IP Right Cessation
- 1989-09-07 CN CN89106978A patent/CN1025197C/zh not_active Expired - Fee Related
- 1989-09-08 UA UA4742029A patent/UA13480A/uk unknown
- 1989-09-08 SU SU894742029A patent/SU1739851A3/ru active
1994
- 1994-01-27 LT LTIP1811A patent/LT3946B/lt not_active IP Right Cessation

Also Published As

Publication number	Publication date
AU616301B2 (en)	1991-10-24
IL91544A0 (en)	1990-04-29
ZA896682B (en)	1990-08-29
PT91656A (pt)	1990-03-30
FI89363B (fi)	1993-06-15
NZ230555A (en)	1991-02-26
DK441689D0 (da)	1989-09-07
CS8905106A3 (en)	1992-01-15
AU4109889A (en)	1990-03-15
NO893428L (no)	1990-03-09
HU201330B (en)	1990-10-28
KR900004747A (ko)	1990-04-12
YU171789A (en)	1991-04-30
NO893428D0 (no)	1989-08-25
JPH02115189A (ja)	1990-04-27
FI89363C (fi)	1993-09-27
CN1025197C (zh)	1994-06-29
ATA220288A (de)	1991-07-15
FI894193A7 (fi)	1990-03-09
CS275035B2 (en)	1992-01-15
UA13480A (uk)	1997-04-25
EP0358116A2 (de)	1990-03-14
LTIP1811A (en)	1995-08-25
CN1040983A (zh)	1990-04-04
HUT51631A (en)	1990-05-28
PH26102A (en)	1992-02-06
DK441689A (da)	1990-03-12
PT91656B (pt)	1995-05-31
LT3946B (en)	1996-05-27
EP0358116A3 (de)	1991-08-21
FI894193A0 (fi)	1989-09-06
SU1739851A3 (ru)	1992-06-07
AT394046B (de)	1992-01-27
MY105044A (en)	1994-07-30
US4978671A (en)	1990-12-18

Legal Events

Date	Code	Title	Description
1995-03-02	ENJ	Ceased due to non-payment of renewal fee

Publication	Publication Date	Title
CH630912A5 (de)	1982-07-15	Verfahren zur herstellung von 1,2-dihydronaphthalinderivaten.
DE3125471A1 (de)	1982-03-18	"piperazinderivate, verfahren zu ihrer herstellung und arzneimittel, die diese verbindungen enthalten"
EP0621037B1 (de)	1999-07-07	Pyrido-pyrimidindione, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE2931418A1 (de)	1980-02-28	Neue imidazochinoxaline und deren salze, verfahren zu deren herstellung, deren verwendung als arzneimittel und die sie enthaltenden pharmazeutischen zusammensetzungen
DE2523103A1 (de)	1976-12-09	Neue propargyl-2-phenylamino-imidazoline-(2), deren saeureadditionssalze, diese enthaltende arzneimittel und verfahren zur herstellung derselben
EP0576906A1 (de)	1994-01-05	Neue Thienothiazinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Antiinflammatorium und Analgeticum
AT391316B (de)	1990-09-25	Neue thienyloxy-alkylamin-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE1910930A1 (de)	1969-10-16	Verfahren zur Herstellung von neuen 1,6-Dimethyl-10alpha-ergolinderivaten
EP0461574B1 (de)	1997-09-24	3,7-Diazabicyclo(3,3,1)-nonan-Verbindungen enthaltende Arzneimittel
DE1695812C3 (de)	1980-10-16	Dibenzo [c,f] -1,2-thiazepin-derivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zubereitung
DD202563A5 (de)	1983-09-21	Verfahren zur herstellung von 1,5-diphenylpyrazolin-3-on-verbindungen
EP0328913B1 (de)	1994-06-08	Neue basisch substituierte 5-Halogen-Thienoisothiazol-3(2H)-on-1,1-dioxide, ein Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Präparate
EP0313935B1 (de)	1994-07-27	Enolether von 6-Chlor-4-hydroxy-2-methyl-N-(2-pyridyl)-2H-thieno(2,3-e)-1,2-thiazin-3-carbonsäureamid-1,1-dioxid, ein Verfahren zu ihrer Herstellung sowie ihre Verwendung
EP0180833B1 (de)	1989-07-19	4-Oxo-pyrido[2,3]pyrimidin-Derivate, Verfahren zur deren Herstellung und diese ethaltende Arzneimittel
EP0213295B1 (de)	1991-04-10	Neue Thieno-1,2-thiazolderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate
EP0177907A1 (de)	1986-04-16	Neue 2-Pyridin-thiol-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate
DD284236A5 (de)	1990-11-07	Verfahren zur herstellung neuer thieno(3',4'-4,5)imidazo(2,1-b)thiazol-derivate
DE2530515C2 (de)	1983-12-01	4- bzw. 7-Hydroxy-4,5,6,7-tetrahydrothieno-[3,2-c] bzw.[2,3-c] pyridine, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittelzubereitungen
EP0030343A1 (de)	1981-06-17	Substituierte 2-Amino-3,4-dihydropyridinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE2221808C2 (de)	1985-06-20	Hydrazinopyridazin-Derivate, deren Säureadditionssalze, Verfahren zu deren Herstellung und Heilmittel
DE2636866A1 (de)	1977-03-03	Neue phenothiazinderivate und deren herstellung
DE2701511A1 (de)	1977-07-28	Thieno(3,2-c)pyridinderivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
DE2222931C3 (de)	1978-07-06	Piperidinoalkylphenthiazine, Verfahren zur Herstellung derselben sowie diese enthaltende pharmazeutische Mittel
DD268473A5 (de)	1989-05-31	Ein verfahren zur herstellung von neuen thieno-imidazo(2,1-b)thiazolderivaten
EP0219747B1 (de)	1990-05-16	Neue 2-(2-Thienyl)-imidazo(4,5-c)pyridinderivate und deren Salze, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate